House Committee Advances Bill to Restrict Chinese Biotech Firms’ Access to US Market
‘This bill is a necessary step towards protecting America’s sensitive healthcare data’ from the Chinese regime, says Rep. James Comer. The House has advanced a bipartisan bill aimed at preventing U.S. taxpayer dollars from flowing to Chinese biotechnology firms that pose a national security threat. The BIOSECURE Act (H.R. 8333) was approved by the House